ALHC · Alignment Healthcare, Inc.
Market Cap
$2.75B
Shares
207.44M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$3.95B
+46.1%
FY2025
Net Income
-$724K
+99.4%
FY2025
Operating Margin
0.37%
+4.1pp
FY2025
Diluted EPS
$0.00
+100%
FY2025
Operating Cash Flow
$139.93M
+302.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $4.58B | $3.95B | $2.7B | $1.82B | $1.43B | $1.17BG | $959.22M | $756.96M | |
| $4.54B | $3.91B | $2.67B | $1.8B | $1.43B | $1.17B | $955.39M | $753.97M | |
| $487.92M | $443.41M | $371.37M | $307.43M | $295.65M | $290.99M | $156.4M | $110.13M | |
| $0 | $634K | $702K | $226K | $386K | $362K | $327K | $327K | |
| $31.5M | $30.4M | $26.87M | $21.41M | $17.27M | $15.81M | $15.1M | $14.92M | |
| $4.52B | $3.93B | $2.81B | $1.95B | $1.56B | $1.35B | $964.49M | $786.45M | |
| $55M | $14.75M | -$101.56M | -$127.82M | -$128.64M | -$178.07M | -$5.26M | -$29.48M | |
| — | 0.37% | -3.76% | -7.01% | -8.97% | -15.25% | -0.55% | -3.9% | |
| $86.5M | $45.16M | -$74.68M | -$106.4M | -$111.37M | -$162.26M | $9.83M | -$14.56M | |
| $16.24M | $15.8M | $23.55M | $21.23M | $18.29M | $17.44M | $16.93M | $14.9M | |
| -$16.24M | -$15.71M | -$26.5M | -$20.38M | -$20.66M | -$17.21M | -$17.66M | -$15.25M | |
| $38.77M | -$958K | -$128.05M | -$148.2M | -$149.3M | -$195.29M | -$22.93M | -$44.73M | |
| -$1.93M | $20K | $21K | -$22K | $339K | $0 | $0 | $0 | |
| $40.7M | -$724K | -$128.04M | -$148.02M | -$149.55M | -$195.29M | -$22.93M | -$44.73M | |
| — | -0.02% | -4.74% | -8.12% | -10.43% | -16.72% | -2.39% | -5.91% | |
| $0 | -$254K | -$36K | -$156K | -$92K | $0 | $0 | — | |
| USD/shares | $0.21 | $0.00 | -$0.67 | -$0.79 | -$0.83 | -$1.14 | -$0.15 | — |
| USD/shares | $0.20 | $0.00 | -$0.67 | -$0.79 | -$0.83 | -$1.14 | -$0.15 | — |
| shares | — | 198.01M | 190.79M | 186.21M | 181.21M | 181.92M | 161.32M | 147.16M |
| shares | — | 198.01M | 190.79M | 186.21M | 181.21M | 181.92M | 0 | 0 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.52×
Healthcare Plans median 0.43×
EV/EBIT
43.18×
Healthcare Plans median 18.53×
P/E (TTM)
—
Healthcare Plans median 22.23×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Reportable Segment | $3,948,719,000 | $2,703,561,000 | $1,823,630,000 | $1,434,159,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Realizing Equity Access and Community Health REACH Model | $1,244,000 | $984,000 | $123,972,000 | $50,946,000 | — | — | — |
| Directly From Centers For Medicare And Medicaid Services | — | — | $123,972,000 | $50,946,000 | $37,737,000 | — | — |
| Health Care Capitation | — | — | $132,802,000 | $59,216,000 | $46,221,000 | $82,335,000 | $124,569,000 |
| Health Care Premium | — | — | $1,668,131,000 | $1,372,334,000 | $1,120,864,000 | $873,058,000 | $629,404,000 |
Key facts
CIK
1832466
CUSIP
01625V104
13F (30d)
245 filings
245 filers
Visit website
Investor relations